Diagnostic Utility of a Custom 34-Gene Anchored Multiplex PCR-Based Next-Generation Sequencing Fusion Panel for the Diagnosis of Bone and Soft Tissue Neoplasms With Identification of Novel USP6 Fusion Partners in Aneurysmal Bone Cysts.

Autor: Dermawan JK; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato)., Cheng YW; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato)., Tu ZJ; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato)., Meyer A; The Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City (Meyer)., Habeeb O; The Department of Anatomic Pathology, Middlemore Hospital, Counties Manukau District Health Board, Auckland, New Zealand (Habeeb)., Zou Y; The Department of Pathology, Kaiser Permanente Oakland Medical Center, Oakland, California (Zou)., Goldblum JR; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato)., Billings SD; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato)., Kilpatrick SE; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato)., Reith JD; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato)., Shurtleff SA; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato)., Farkas DH; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato)., Rubin BP; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato)., Azzato EM; From Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dermawan, Cheng, Tu, Goldblum, Billings, Kilpatrick, Reith, Shurtleff, Farkas, Rubin, Azzato).

Publikováno v: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2021 Jul 01; Vol. 145 (7), pp. 851-863.

Machine learning-based evaluation of prognostic factors for mortality and relapse in patients with acute lymphoblastic leukemia: a comparative simulation study.

Autor: Mehrbakhsh, Zahra^1,2 (AUTHOR), Hassanzadeh, Roghayyeh^1,2 (AUTHOR), Behnampour, Nasser³ (AUTHOR), Tapak, Leili^1,4 (AUTHOR) l.tapak@umsha.ac.ir, Zarrin, Ziba⁵ (AUTHOR), Khazaei, Salman⁶ (AUTHOR), Dinu, Irina⁷ (AUTHOR)

Publikováno v: BMC Medical Informatics & Decision Making. 9/16/2024, Vol. 24 Issue 1, p1-16. 16p.

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

Autor: Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, Lu C, Chen SC, Wei L, Collins-Underwood JR, Ma J, Roberts KG, Pounds SB, Ulyanov A, Becksfort J, Gupta P, Huether R, Kriwacki RW, Parker M, McGoldrick DJ, Zhao D, Alford D, Espy S, Bobba KC, Song G, Pei D, Cheng C, Roberts S, Barbato MI, Campana D, Coustan-Smith E, Shurtleff SA, Raimondi SC, Kleppe M, Cools J, Shimano KA, Hermiston ML, Doulatov S, Eppert K, Laurenti E, Notta F, Dick JE, Basso G, Hunger SP, Loh

Publikováno v: Nature Genetics.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=erc_________::ffdffd816eb1eda581ae80dad835f9ae

Enrichment of heterozygous germline RECQL4 loss-of-function variants in pediatric osteosarcoma.

Autor: Maciaszek JL; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Oak N; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Chen W; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Hamilton KV; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., McGee RB; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Nuccio R; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Mostafavi R; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Hines-Dowell S; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Harrison L; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Taylor L; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Gerhardt EL; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Ouma A; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Edmonson MN; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Patel A; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Nakitandwe J; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Pappo AS; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Azzato EM; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Shurtleff SA; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Ellison DW; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Downing JR; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Hudson MM; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Robison LL; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Santana V; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Newman S; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Zhang J; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Wang Z; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Wu G; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Nichols KE; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA., Kesserwan CA; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

Publikováno v: Cold Spring Harbor molecular case studies [Cold Spring Harb Mol Case Stud] 2019 Oct 23; Vol. 5 (5). Date of Electronic Publication: 2019 Oct 23 (Print Publication: 2019).

Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia.

Autor: van Oosterwijk JG; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Buelow DR; Division of Pharmaceutics, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA., Drenberg CD; Division of Pharmaceutics, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA., Vasilyeva A; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Li L; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Shi L; Department of Biostatistics., Wang YD; Department of Computational Biology., Finkelstein D; Department of Computational Biology., Shurtleff SA; Department of Pathology, and., Janke LJ; Department of Pathology, and., Pounds S; Department of Biostatistics., Rubnitz JE; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Inaba H; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Pabla N; Division of Pharmaceutics, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA., Baker SD; Division of Pharmaceutics, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2018 Jan 02; Vol. 128 (1), pp. 369-380. Date of Electronic Publication: 2017 Dec 11.